Cargando…

Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway

Accumulating evidence shows that peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) is involved in the progression of hormone-related cancers, and there may exist an association between estrogen and PGC-1α. Notably, emerging evidence has led to considerable interest in the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hui, Yang, Rui, Liu, Hao, Ren, Zhongqian, Kong, Fanfei, Li, Da, Ma, Xiaoxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935004/
https://www.ncbi.nlm.nih.gov/pubmed/27418839
http://dx.doi.org/10.2147/OTT.S103482
_version_ 1782441411330703360
author Yang, Hui
Yang, Rui
Liu, Hao
Ren, Zhongqian
Kong, Fanfei
Li, Da
Ma, Xiaoxin
author_facet Yang, Hui
Yang, Rui
Liu, Hao
Ren, Zhongqian
Kong, Fanfei
Li, Da
Ma, Xiaoxin
author_sort Yang, Hui
collection PubMed
description Accumulating evidence shows that peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) is involved in the progression of hormone-related cancers, and there may exist an association between estrogen and PGC-1α. Notably, emerging evidence has led to considerable interest in the role of PGC-1α in endometrial cancer development. However, whether the synergism exists between PGC-1α and estrogen for regulating mitochondrial function to promote the development of endometrial cancer remains largely unknown. Here, we show that: 1) knockdown of PGC-1α attenuates the survival of endometrial cancer cells by inducing cell apoptosis through the mitochondrial pathway; 2) estrogen remedies the PGC-1α efficiency-induced decline of endometrial cancer cell viability; and 3) estrogen modulates the mitochondrial function to inhibit the PGC-1α deficiency-induced apoptosis in endometrial cancer cells. Collectively, these results demonstrated that the synergism between PGC-1α and estrogen was required for the survival of endometrial cancer cells, which was dependent on the mitochondrial pathway.
format Online
Article
Text
id pubmed-4935004
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-49350042016-07-14 Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway Yang, Hui Yang, Rui Liu, Hao Ren, Zhongqian Kong, Fanfei Li, Da Ma, Xiaoxin Onco Targets Ther Original Research Accumulating evidence shows that peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) is involved in the progression of hormone-related cancers, and there may exist an association between estrogen and PGC-1α. Notably, emerging evidence has led to considerable interest in the role of PGC-1α in endometrial cancer development. However, whether the synergism exists between PGC-1α and estrogen for regulating mitochondrial function to promote the development of endometrial cancer remains largely unknown. Here, we show that: 1) knockdown of PGC-1α attenuates the survival of endometrial cancer cells by inducing cell apoptosis through the mitochondrial pathway; 2) estrogen remedies the PGC-1α efficiency-induced decline of endometrial cancer cell viability; and 3) estrogen modulates the mitochondrial function to inhibit the PGC-1α deficiency-induced apoptosis in endometrial cancer cells. Collectively, these results demonstrated that the synergism between PGC-1α and estrogen was required for the survival of endometrial cancer cells, which was dependent on the mitochondrial pathway. Dove Medical Press 2016-06-30 /pmc/articles/PMC4935004/ /pubmed/27418839 http://dx.doi.org/10.2147/OTT.S103482 Text en © 2016 Yang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Yang, Hui
Yang, Rui
Liu, Hao
Ren, Zhongqian
Kong, Fanfei
Li, Da
Ma, Xiaoxin
Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway
title Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway
title_full Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway
title_fullStr Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway
title_full_unstemmed Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway
title_short Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway
title_sort synergism between pgc-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935004/
https://www.ncbi.nlm.nih.gov/pubmed/27418839
http://dx.doi.org/10.2147/OTT.S103482
work_keys_str_mv AT yanghui synergismbetweenpgc1aandestrogeninthesurvivalofendometrialcancercellsviathemitochondrialpathway
AT yangrui synergismbetweenpgc1aandestrogeninthesurvivalofendometrialcancercellsviathemitochondrialpathway
AT liuhao synergismbetweenpgc1aandestrogeninthesurvivalofendometrialcancercellsviathemitochondrialpathway
AT renzhongqian synergismbetweenpgc1aandestrogeninthesurvivalofendometrialcancercellsviathemitochondrialpathway
AT kongfanfei synergismbetweenpgc1aandestrogeninthesurvivalofendometrialcancercellsviathemitochondrialpathway
AT lida synergismbetweenpgc1aandestrogeninthesurvivalofendometrialcancercellsviathemitochondrialpathway
AT maxiaoxin synergismbetweenpgc1aandestrogeninthesurvivalofendometrialcancercellsviathemitochondrialpathway